secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001193125-24-226929
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres stockholders approve sale of VOWST business to Nestlé; close expected Sept 30
--------------------------------------------------------------------------------

- Stockholders voted 77.1M for, 7.1M against, and 0.2M abstain to approve the sale of VOWST business to Société des Produits Nestlé S.A.
- Non-binding advisory compensation proposal for named executives also passed (63.1M for, 20.9M against, 0.4M abstain).
- Transaction expected to close on September 30, 2024, subject to customary closing conditions.
- VOWST is a microbiome therapeutic; the sale was originally announced under an asset purchase agreement dated August 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524226929/0001193125-24-226929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524226929/d713439d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-226929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer